Acetylator phenotype in spontaneous SLE and rheumatoid arthritis.
Open Access
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 38 (2) , 171-173
- https://doi.org/10.1136/ard.38.2.171
Abstract
Acetylator phenotype was determined in 22 patients with spontaneous systemic lupus erythematosus and the proportion of 'slow' acetylators compared with that obtained in a group of patients with rheumatoid arthritis and a group of healthy controls. 73% of the SLE group were designated 'slow' compared with 72% of the rheumatoid group and 64% of the control group. These differences were not significant.Keywords
This publication has 10 references indexed in Scilit:
- Evaluation of the Sulphapyridine Acetylator Phenotyping Test in Healthy Subjects and in Patients with Cardiac and Renal DiseasesActa Medica Scandinavica, 1977
- Spontaneous Systemic Lupus Erythematosus and Acetylator PhenotypeActa Medica Scandinavica, 1977
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977
- Drug-Induced Antinuclear Antibodies and Lupus SyndromesDrugs, 1976
- The acetylator phenotype of patients with systemic lupus erythematosus.1974
- Simplified Method for Determining Acetylator PhenotypeBMJ, 1972
- Relation of hydralazine plasma concentration to dosage and hypotensive actionClinical Pharmacology & Therapeutics, 1972
- The polymorphic acetylation of dapsone in manClinical Pharmacology & Therapeutics, 1971
- HUMAN ACETYLATION POLYMORPHISM1964
- Genetic Control of Isoniazid Metabolism in ManBMJ, 1960